{
  "Workup and Treatment of M0 Castration-Resistant Prostate Cancer (CRPC)": {
    "Initial Condition": "CRPC, imaging studies negative for distant metastases",
    "Primary Management": {
      "Continue ADTᶜ,ᶻ": "Maintain castrate serum levels of testosterone (<50 ng/dL)",
      "PSADT >10 mo": {
        "Therapy Options": [
          "Monitoringʲʲ (preferred)",
          "Other secondary hormone therapyᶻ"
        ]
      },
      "PSADT ≤10 mo": {
        "Preferred Regimens": [
          "Apalutamideᶻ (category 1)",
          "Darolutamideᶻ (category 1)",
          "Enzalutamideᶻ (category 1)"
        ],
        "Other Recommended Regimens": [
          "Other secondary hormone therapyᶻ"
        ],
        "Follow-up": "Consider periodic disease assessment (PSA and imaging)ᶠ",
        "Results": {
          "Stable PSA and no evidence of metastases": {
            "Action": "Maintain current treatment and consider periodic disease assessment (PSA and imaging)ᶠ"
          },
          "PSA increasing or radiographic evidence of metastases": {
            "Action": "Imagingᶠ,ᶠᶠ",
            "Result": {
              "No metastases (M0)": "Change or maintain current treatment and continue periodic disease assessment",
              "Metastases (M1)": "See Workup and Treatment of M1 CRPC (PROS-15)"
            }
          }
        }
      }
    }
  }
}